Postpartum women are at increased risk of blood clots for twice as long as previously believed, according to new research, which stopped short of suggesting the use of prophylactic anticoagulant therapy in high-risk patients continue beyond the recommended 6 weeks after delivery.
As pharmacists we are able to identify the differences between asthma and COPD and the appropriate non-pharmacological and pharmacological treatments. Although there are many references within the literature to support the most optimum treatment of both diseases, both the National Heart, Lung, and Blood Institute Guidelines for the Diagnosis and Management of Asthma (EPR-3) 2007 guidelines and the Global Initiative of Chronic Obstructive Lung Disease (GOLD) 2014 guidelines are considered the standard of care for both patient populations. Both references provide a detailed overview of both diseases including the most optimum pharmacological treatment strategies. 1, 2